Primary Cells Market, By Type (Hematopoietic, Keratinocytes, Hepatocytes, Gastrointestinal, Lung, Renal, Heart, and Musculoskeletal), By Origin, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5567
|
Published Date
July 2026
|
Pages
383
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Primary Cells Market size was valued at US$ 1,809.7 Million in 2025, expanding at a CAGR of 9.6% from 2026 to 2033.
The primary cells market plays a critical role in life sciences research, drug discovery, and the biopharmaceutical industry by providing cells directly isolated from animal or human tissues that preserve many of the biological characteristics of their original source. Unlike immortalized cell lines, primary cells more closely replicate natural tissue behavior, making them valuable tools for disease modeling, toxicity testing, therapeutic target identification, and the development of new medicines. Human primary cells represent the larger share of usage due to their relevance in translational research, while animal-derived primary cells also hold significant importance in applications such as vaccine development, preclinical testing, toxicology studies, and fundamental biological research.
Advancements in cell culture technologies, including three-dimensional (3D) cell models, organoid development, and precision medicine approaches, are further increasing the demand for primary cells by enabling researchers to create more accurate and patient-relevant biological models. According to the World Health Organization (WHO), noncommunicable diseases account for approximately 74% of deaths worldwide, highlighting the growing need for advanced research tools to understand disease mechanisms and develop effective treatments. Furthermore, according to the International Agency for Research on Cancer (IARC), cancer accounted for nearly 20 million new cases and approximately 9.7 million deaths globally in 2022, reinforcing the importance of advanced cellular models in oncology research. As pharmaceutical companies and research institutions increasingly focus on personalized medicine and targeted therapies, primary cells are expected to remain a vital component of biomedical innovation and drug development pipelines.
Primary Cells Market- Market Dynamics
Advancements in 3D Cell Culture and Personalized Medicine Boosting Market Adoption
The primary cells market is undergoing a significant transformation as researchers increasingly shift from traditional two-dimensional (2D) cell culture models toward advanced three-dimensional (3D) culture technologies, including spheroids, organoids, and organ-on-a-chip systems. This transition is driven by the limitations of 2D culture models, which often fail to accurately replicate the complex cellular organization, cell-to-cell interactions, and tissue microenvironment observed in living organisms. As a result, conventional models may have limited predictive accuracy during drug development, contributing to challenges in translating laboratory findings into successful clinical outcomes. According to the U.S. Food and Drug Administration (FDA), approximately 90% of drug candidates entering clinical trials fail to achieve regulatory approval, with insufficient efficacy and safety concerns among the major factors contributing to clinical failure.
As pharmaceutical and biotechnology companies increasingly prioritize more reliable and predictive research models, the adoption of primary-cell-based 3D platforms and organoid technologies is expanding. These advanced models are creating greater demand for high-quality primary cell sources, particularly for applications such as oncology research, liver toxicity studies, respiratory disease modeling, and regenerative medicine. Additionally, the growth of personalized medicine is further accelerating the need for patient-specific cellular models. According to the National Institutes of Health (NIH), the All of Us Research Program has enrolled more than one million participants, creating one of the largest and most diverse biomedical datasets to support individualized healthcare research. These developments are enabling researchers to better understand disease mechanisms, improve therapeutic discovery, and develop more targeted and effective treatments, thereby supporting long-term growth of the primary cells market.
Primary Cells Market- Segmentation Analysis:
The Global Primary Cells Market is segmented on the basis of Type, Origin, Application, End User, and Region.
By type, hematopoietic stem and progenitor cells are witnessing strong demand due to the rapid expansion of CAR-T cell therapies and other adoptive cell therapy programs. According to the Alliance for Regenerative Medicine (ARM), more than 2,000 regenerative medicine and advanced therapy clinical trials are ongoing worldwide, with many involving hematopoietic stem cells. Keratinocyte-based primary cells are widely used in research related to dermatological disorders, wound healing, and ophthalmic diseases. Hepatocytes play a critical role in drug metabolism and hepatotoxicity testing, as the liver is the primary organ responsible for xenobiotic processing in the human body. According to the World Health Organization (WHO), approximately 254 million people were living with chronic hepatitis B and around 50 million with chronic hepatitis C in 2022, highlighting the continued global burden of liver diseases and the need for advanced research models. Gastrointestinal primary cells are also gaining increasing attention due to their applications in disease modeling and therapeutic development.
Based on origin, human primary cells represent a significant segment due to their ability to closely replicate human physiological, pharmacological, and genetic responses. These cells provide valuable insights into disease mechanisms, drug discovery, and personalized medicine approaches. Animal primary cells continue to play an important role in biological research, veterinary applications, vaccine development, and early-stage toxicology studies. According to the European Commission, approximately 7.1 million animals were used for research purposes in the European Union in 2022, supporting the continued relevance of animal-derived research models. Overall, the demand for primary cells is increasing, driven by advancements in precision medicine, gene therapy, regenerative medicine, and the development of more sophisticated disease models.
Primary Cells Market- Geographical Insights
North America holds a leading position in the global primary cells market, supported by its well-established biotechnology and pharmaceutical industries, strong research funding ecosystem, and advanced cell biology infrastructure. The region accounts for a significant share of global demand due to the presence of leading academic institutions, biopharmaceutical companies, and specialized research facilities involved in drug discovery, regenerative medicine, and cell-based research. According to ClinicalTrials.gov, the United States contributes more than one-third of registered clinical studies worldwide, highlighting its dominant role in biomedical research and clinical innovation. In addition, the U.S. Food and Drug Administration (FDA) is encouraging the development and adoption of advanced cell-based testing approaches as alternatives to certain animal-based models, increasing demand for high-quality human primary cells. According to the Alliance for Regenerative Medicine (ARM), the United States has the largest concentration of regenerative medicine clinical trials globally, further strengthening the region’s position in the primary cells market.
Asia-Pacific is expected to experience significant growth in the primary cells market, driven by expanding biotechnology research capabilities, increasing investments in life sciences, and government support for healthcare innovation. Countries such as China, Japan, South Korea, and India are strengthening their biomedical research infrastructure while benefiting from comparatively lower research and development costs. According to the UNESCO Institute for Statistics, China has become the world’s second-largest investor in research and development, while Japan and South Korea continue to rank among the highest global R&D investors as a percentage of GDP. India is also emerging as a major contributor to the global healthcare ecosystem, particularly in vaccine manufacturing. According to the World Health Organization (WHO) and India’s Department of Biotechnology, the country supplies approximately 60% of global vaccine doses by volume, reflecting its growing capabilities in biological research and production. These developments are expected to support increasing adoption of primary cells for drug discovery, disease modeling, and advanced biomedical applications across the Asia-Pacific region.
Primary Cells Market- Competitive Landscape:
The competitive landscape of the primary cells market is characterized by the presence of established life sciences suppliers offering a broad range of products, including primary cells, cell culture media, reagents, and supporting research equipment. Leading companies such as Thermo Fisher Scientific Inc., Lonza Group AG, and Merck KGaA maintain strong market positions through extensive product portfolios, global distribution networks, manufacturing capabilities, and continuous investments in cell biology technologies. According to the Alliance for Regenerative Medicine (ARM), more than 2,000 regenerative medicine and advanced therapy clinical trials are underway globally, highlighting the increasing demand for high-quality primary cells and advanced cellular research tools. Specialized suppliers such as PromoCell GmbH, STEMCELL Technologies Inc., and ATCC compete by offering highly characterized donor-derived cells, specialized tissue types, and application-specific solutions for disease modeling, drug discovery, regenerative medicine, and personalized healthcare research. In addition, companies such as BioIVT, Cureline Inc., and iXCells Biotechnologies contribute to market growth by providing customized cell sourcing, advanced characterization, and research-grade primary cell solutions.
Recent Developments
- In 2025, Thermo Fisher Scientific Inc. acquired the Filtration and Separation business from Solventum, strengthening its capabilities in bioprocessing, cell culture workflows, and bioproduction technologies. The acquisition supports Thermo Fisher’s broader portfolio of solutions used in cell therapy, stem cell research, and advanced biological manufacturing.
- In 2024, Merck KGaA announced an agreement to acquire HUB Organoids Holding B.V., expanding its capabilities in advanced cell culture technologies through organoid-based models. The acquisition supports the development of more predictive drug discovery platforms and aligns with the growing adoption of three-dimensional cell culture approaches as alternatives to traditional research models.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRIMARY CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific Inc.
- FUJIFILM Irvine Scientific
- AcceGen
- Takara Bio Inc.
- Cyagen Biosciences
- Lonza Group AG
- Merck KGaA
- PromoCell GmbH
- Cell Biologics Inc.
- ZenBio Inc.
- STEMCELL Technologies Inc.
- AllCells LLC
- American Type Culture Collection (ATCC)
- Axol Bioscience Ltd.
- Creative Bioarray
- ScienCell Research Laboratories Inc.
- BioIVT
- Corning Incorporated
- Bio-Techne Corporation
- Charles River Laboratories International Inc.
- Cureline Inc.
- Cell Applications Inc.
- iXCells Biotechnologies
- Neuromics
- Others
GLOBALPRIMARY CELLS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Hematopoietic
- Keratinocytes
- Hepatocytes
- Gastrointestinal
- Lung
- Renal
- Heart
- Musculoskeletal
- Others
GLOBAL PRIMARY CELLS MARKET, BY ORIGIN- MARKET ANALYSIS, 2020 - 2033
- Human Primary Cells
- Animal Primary Cells
GLOBAL PRIMARY CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Drug Discovery
- ADME & Toxicology Testing
- Disease Modeling
- Regenerative Medicine
- Cell & Gene Therapy Research
- Others
GLOBAL PRIMARY CELLS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Life Science Research Companies
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Others
GLOBAL PRIMARY CELLS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Primary Cells Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Primary Cells Market Snippet by Type
2.1.2. Primary Cells Market Snippet by Origin
2.1.3. Primary Cells Market Snippet by Application
2.1.4. Primary Cells Market Snippet by End User
2.1.5. Primary Cells Market Snippet by Country
2.1.6. Primary Cells Market Snippet by Region
2.2. Competitive Insights
3. Primary Cells Key Market Trends
3.1. Primary Cells Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Primary Cells Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Primary Cells Market Opportunities
3.4. Primary Cells Market Future Trends
4. Primary Cells Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Primary Cells Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Primary Cells Market Landscape
6.1. Primary Cells Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Primary Cells Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
7.1.2. Hematopoietic
7.1.3. Keratinocytes
7.1.4. Hepatocytes
7.1.5. Gastrointestinal
7.1.6. Lung
7.1.7. Renal
7.1.8. Heart
7.1.9. Musculoskeletal
8. Primary Cells Market – By Origin
8.1. Overview
8.1.1. Segment Share Analysis, By Origin, 2025 & 2033 (%)
8.1.2. Human Primary Cells
8.1.3. Animal Primary Cells
9. Primary Cells Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
9.1.2. Drug Discovery
9.1.3. ADME & Toxicology Testing
9.1.4. Disease Modeling
9.1.5. Regenerative Medicine
9.1.6. Cell & Gene Therapy Research
10. Primary Cells Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
10.1.2. Life Science Research Companies
10.1.3. Pharmaceutical & Biotechnology Companies
10.1.4. Research Institutes
10.1.5. Others
11. Primary Cells Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Primary Cells Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Primary Cells Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Primary Cells Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Primary Cells Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Primary Cells Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Origin, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Primary Cells Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Thermo Fisher Scientific Inc.
12.2.2. FUJIFILM Irvine Scientific
12.2.3. AcceGen
12.2.4. Takara Bio Inc.
12.2.5. Cyagen Biosciences
12.2.6. Lonza Group AG
12.2.7. Merck KGaA
12.2.8. PromoCell GmbH
12.2.9. Cell Biologics Inc.
12.2.10. ZenBio Inc.
12.2.11. STEMCELL Technologies Inc.
12.2.12. AllCells LLC
12.2.13. American Type Culture Collection (ATCC)
12.2.14. Axol Bioscience Ltd.
12.2.15. Creative Bioarray
12.2.16. ScienCell Research Laboratories Inc.
12.2.17. BioIVT
12.2.18. Corning Incorporated
12.2.19. Bio-Techne Corporation
12.2.20. Charles River Laboratories International Inc.
12.2.21. Cureline Inc.
12.2.22. Cell Applications Inc.
12.2.23. iXCells Biotechnologies
12.2.24. Neuromics
12.2.25. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PRIMARY CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific Inc.
- FUJIFILM Irvine Scientific
- AcceGen
- Takara Bio Inc.
- Cyagen Biosciences
- Lonza Group AG
- Merck KGaA
- PromoCell GmbH
- Cell Biologics Inc.
- ZenBio Inc.
- STEMCELL Technologies Inc.
- AllCells LLC
- American Type Culture Collection (ATCC)
- Axol Bioscience Ltd.
- Creative Bioarray
- ScienCell Research Laboratories Inc.
- BioIVT
- Corning Incorporated
- Bio-Techne Corporation
- Charles River Laboratories International Inc.
- Cureline Inc.
- Cell Applications Inc.
- iXCells Biotechnologies
- Neuromics
- Others
GLOBALPRIMARY CELLS MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033
- Hematopoietic
- Keratinocytes
- Hepatocytes
- Gastrointestinal
- Lung
- Renal
- Heart
- Musculoskeletal
- Others
GLOBAL PRIMARY CELLS MARKET, BY ORIGIN- MARKET ANALYSIS, 2020 - 2033
- Human Primary Cells
- Animal Primary Cells
GLOBAL PRIMARY CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Drug Discovery
- ADME & Toxicology Testing
- Disease Modeling
- Regenerative Medicine
- Cell & Gene Therapy Research
- Others
GLOBAL PRIMARY CELLS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Life Science Research Companies
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Others
GLOBAL PRIMARY CELLS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
